
Research from University College London has warned that freshwater sources in the English capital of London contain high levels of …

NICE has published final guidance which approves AstraZeneca’s Lynparza (olaparib) for use on the NHS as a maintenance therapy for …

Britain’s cost-effectiveness body NICE has said it will review the methods it uses to develop guidance on drugs, medical devices, …

The Department of Health and Social Care paid £9.2 billion to private providers in the year prior to 31 March …

A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the …

Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (CDK4/6) …

GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at …

The NHS has said it will test the world’s first subscription style payment model to pay for antibiotics. Britain’s National …

It’s good news for UK patients as it emerges that the National Institute of Health and Care Excellence has passed …

NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a …

The British government has called for more research into cannabis-based medicinal products (CBMPs). In a paper published on 3 July, …

Hospitals in Oxfordshire have introduced a genetic test which helps doctors predict the dangerous side effects of chemotherapy. In …

The latest monthly edition of Pharmafocus, the July/August issue, is available to read for free online now!The UK remains split …

A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in …

An outbreak of the rare contagious bacteria Group A streptococcal (iGAS) infection in Essex, UK, has resulted in 32 cases …